Eagle Capital Management (Louisiana)’s Biogen BIIB Stock Holding History

Eagle Capital Management (Louisiana)’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-8,542	Closed	-$3.45M	–	30
2015 Q2	$3.45M	Sell	8,542 -22	-0.3%	-$8.83K	2%	20
2015 Q1	$3.62M	Sell	8,564 -42	-0.5%	-$16.6K	1.91%	17
2014 Q4	$2.92M	Buy	8,606 +52	+0.6%	+$16.8K	1.17%	35
2014 Q3	$2.83M	Sell	8,554 -183	-2%	-$60.3K	1.08%	34
2014 Q2	$2.75M	Buy	8,737 +206	+2%	+$62K	1.03%	43
2014 Q1	$2.61M	Buy	8,531 +3,891	+84%	+$1.24M	1.02%	46
2013 Q4	$1.3M	Buy	+4,640	New	+$1.2M	0.56%	44

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Eagle Capital Management (Louisiana)'s BIIB Position: Q3 2015 in Review

Eagle Capital Management (Louisiana) sold out of Biogen (BIIB) in Q3 2015, closing a stake of 8,542 shares — an estimated $3.45M sold.

Eagle Capital Management (Louisiana) first reported a position in BIIB in Q4 2013 and held it in 7 quarters. The position peaked at $3.62M in Q1 2015. 924 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

Eagle Capital Management (Louisiana) reported no remaining Biogen position as of Q3 2015 after selling out during the quarter.
Eagle Capital Management (Louisiana) sold 8,542 Biogen shares in Q3 2015, an estimated $3.45M.
Eagle Capital Management (Louisiana) first reported a position in Biogen in Q4 2013 and held it in 7 quarters.
Eagle Capital Management (Louisiana)'s Biogen position peaked at $3.62M in Q1 2015.
924 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on Eagle Capital Management (Louisiana)'s 13F filing for Q3 2015, filed 16 Nov 2015.